Fleetyr | $750,000 | (Sep 25, 2025)
FYR Bio | $8,000,000 | (Sep 25, 2025)
OnFinance AI | $4,200,000 | (Sep 25, 2025)
Certified by Founder
Lodge
Kano Therapeutics
start up
United States
- Cambridge, Massachusetts
- 13/08/2024
- Seed
- $5,000,000
Kano Therapeutics is a founder-led biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them, empowering scientists, labs, and companies with the building blocks they need to cross the chasm to cures.
- Industry Biotechnology Research
- Website https://kanotherapeutics.com/
- LinkedIn https://www.linkedin.com/company/kano-therapeutics/
Related People
Floris EngelhardtCo Founder
United States -
Cambridge, Massachusetts
Working in Biomolecular Design and DNA Nanotechnology, eager to transfer visions into science and science into real-world applications.
AmplifyMD | $20,000,000 | (Sep 25, 2025)
Synthesized | $20,000,000 | (Sep 25, 2025)
BizzyCar | $20,000,000 | (Sep 25, 2025)
Lifeguard | $1,300,000 | (Sep 25, 2025)
Sparrow Pharmaceuticals, Inc. | $95,000,000 | (Sep 25, 2025)
Belfort | $6,000,000 | (Sep 25, 2025)
Creem | $2,116,601 | (Sep 24, 2025)
Oriane | $1,500,000 | (Sep 24, 2025)
Duel Tech | $16,000,000 | (Sep 24, 2025)